BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.05% | -11.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.05% | -11.77% | |||
| Cost of Revenue | 8.17% | -8.85% | |||
| Gross Profit | 12.76% | -13.42% | |||
| SG&A Expenses | 9.43% | -7.79% | |||
| Depreciation & Amortization | 28.79% | -90.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.58% | -11.76% | |||
| Operating Income | 133.75% | 10.11% | |||
| Income Before Tax | -35.50% | 175.25% | |||
| Income Tax Expenses | 135.84% | -310.98% | |||
| Earnings from Continuing Operations | -43.74% | 239.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -89.29% | 1,682.45% | |||
| EBIT | 133.75% | 10.11% | |||
| EBITDA | 43.48% | -59.39% | |||
| EPS Basic | -89.34% | 1,668.46% | |||
| Normalized Basic EPS | -42.23% | 172.83% | |||
| EPS Diluted | -91.02% | 2,128.00% | |||
| Normalized Diluted EPS | -42.11% | 174.44% | |||
| Average Basic Shares Outstanding | 0.65% | 0.46% | |||
| Average Diluted Shares Outstanding | 0.49% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||